Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Shane K Mathew

1PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Dec 11, 2024
Enoxaparin 40 mg Twice Daily With Peak Anti-Xa Adjustments Is Safe and Necessary to Achieve Therapeutic Chemoprophylaxis in Burn-Injured Patients.

Desiree N Pinto, Sophia Lee, Cory Johnson

Pageof 1

Frequent Collaborators

1 joint publications

Desiree N Pinto

1 joint publications

Sophia Lee

1 joint publications

Cory Johnson

1 joint publications

Rola Halabi

1 joint publications

Tuan D Le

1 joint publications

Bonnie C Carney

1 joint publications

Taryn E Travis

Frequent Collaborators

1 joint publications

Desiree N Pinto

1 joint publications

Sophia Lee

1 joint publications

Cory Johnson

1 joint publications

Rola Halabi

Top Related Videos

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on : Oct 12, 2012

13.7K
See more related videos

Top Related Videos

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on : Oct 12, 2012

13.7K
See more related videos